Scrippsera ANA Reference Control Sera
510(k) K810081
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK810081 | Date9 Feb 1981 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DHN
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.5100
- Advisory Committee
- Immunology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Scrippsera ANA Reference Control Sera is an Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control, classified under FDA product code DHN. This device serves as a reference standard for validating and calibrating immunofluorescent assays used to detect antinuclear antibodies (ANA) in clinical immunology testing. It provides a consistent, standardized control to ensure accuracy and reliability in diagnostic procedures.
Supplied as a liquid, the device is intended for single-use in laboratory settings and requires no special storage conditions beyond refrigeration. It is regulated under FDA regulation 866.5100 and received a 510(k) clearance (K810081) in 1981, classified as substantially equivalent (SESE) by the Immunology (IM) Advisory Committee. The product is not intended for direct patient administration but functions as a quality control measure in serological testing.
Other devices from Scripps-Miles, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the Scrippsera ANA Reference Control Sera used for?
The Scrippsera ANA Reference Control Sera serves as a standardized reference control for validating and calibrating indirect immunofluorescence assays used to detect antinuclear antibodies (ANA) in clinical immunology testing. It helps laboratories maintain accuracy and reliability in diagnostic procedures by providing a consistent benchmark for comparison.
How is the Scrippsera ANA Reference Control Sera supplied and stored?
The product is supplied as a liquid in a single-use format, designed for laboratory use only. It does not require specialized storage conditions beyond standard refrigeration to preserve its integrity and performance.
Is the Scrippsera ANA Reference Control Sera intended for direct patient use?
No, this device is explicitly not intended for direct administration to patients. Instead, it functions solely as a quality control measure in serological testing, ensuring the accuracy of immunofluorescent assays for ANA detection in laboratory settings.
What regulatory pathway does the Scrippsera ANA Reference Control Sera follow?
The Scrippsera ANA Reference Control Sera was cleared through the FDA’s 510(k) process (K810081) in 1981 under product code DHN, classified as substantially equivalent (SESE) by the Immunology (IM) Advisory Committee. It is regulated under FDA regulation 866.5100 and is categorized as a Class II medical device.
Can this control be reused after opening?
The Scrippsera ANA Reference Control Sera is designed for single-use only. Reusing it could compromise the accuracy of assay validation and quality control, as it is intended to provide a consistent baseline for each test run without contamination or degradation.